Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

BACKGROUND: A minimal clinically important difference has not been established for the Abnormal Involuntary Movement Scale in patients with tardive dyskinesia. Valbenazine is a vesicular monoamine transporter 2 inhibitor approved for the treatment of tardive dyskinesia in adults. Efficacy in randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stacy, Mark, Sajatovic, Martha, Kane, John M., Cutler, Andrew J., Liang, Grace S., O'Brien, Christopher F., Correll, Christoph U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772010/
https://www.ncbi.nlm.nih.gov/pubmed/31234240
http://dx.doi.org/10.1002/mds.27769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772010/
https://www.ncbi.nlm.nih.gov/pubmed/31234240
http://dx.doi.org/10.1002/mds.27769

Ejemplares similares